To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene RANGAP1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
526 supporting clones for gene RANGAP1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DA810767 brain .a 1 to 559 2 to 560   tiling clone, capped   559/559
(100 %)
3 diff
(99.5 %id)
DA805691 brain .a 38 to 572 2 to 538   capped   537/537
(100 %)
3 diff
(99.5 %id)
CD722788 eye, lacrimal gland .a 45 to 635 1 to 591   tiling clone,   591/591
(100 %)
0 diff
(100 %id)
BI464897 testis .a 277 to 961 1 to 692   available from MGC,   692/859
(80 %)
19 diff
(97.8 %id)
BC048990 testis .a 282 to 3749 1 to 3468 exact tiling clone, available from MGC, AAA   3468/3468
(100 %)
3 diff
(100.0 %id)
AB058738 brain .b 1 to 4222 20 to 4240 exact tiling clone, available from KIAA,   4221/4240
(99 %)
10 diff
(99.8 %id)
BQ317692 colon .b 634 to 838 1 to 205       205/205
(100 %)
0 diff
(100 %id)
BI828416 brain, medulla .b 900 to 1001 1 to 102       102/102
(100 %)
0 diff
(100 %id)
CR456557   .b 1410 to 3375 1 to 1966 exact tiling clone,   1966/1966
(100 %)
1 diff
(100.0 %id)
BE266132 lung, small cell carcinoma .b 4211 to 4814 1 to 610   tiling clone,   610/611
(99 %)
8 diff
(98.7 %id)
BM682791 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 4515 to 5057 559 to 17   tiling clone, AAA   543/552
(98 %)
0 diff
(100 %id)
DA269460 caudate nucleus .c 1 to 639 2 to 640   tiling clone, capped   639/639
(100 %)
0 diff
(100 %id)
DB098217 testis .c 1 to 592 2 to 594   capped   593/593
(100 %)
1 diff
(99.9 %id)
DA821686 pericardium .c 9 to 582 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
DA026429   .c 10 to 575 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
BP201772 amygdala .c 31 to 603 1 to 573       573/582
(98 %)
1 diff
(99.9 %id)
DA540894 lung .c 32 to 611 2 to 581   capped   580/580
(100 %)
1 diff
(99.9 %id)
BP260034 heart .c 34 to 605 1 to 572       572/572
(100 %)
5 diff
(99.2 %id)
DA792450 brain .c 36 to 600 2 to 566   capped   565/565
(100 %)
2 diff
(99.7 %id)
BP359173 mammary gland .c 36 to 617 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
BP282406 bone marrow .c 37 to 618 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BM148005 leukopheresis .c 37 to 454 1 to 419       419/419
(100 %)
15 diff
(96.5 %id)
DB105927 thymus .c 37 to 598 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
DA476051   .c 38 to 527 2 to 493   capped   492/492
(100 %)
3 diff
(99.4 %id)
DA477896   .c 38 to 610 2 to 576   capped   575/575
(100 %)
3 diff
(99.5 %id)
DA704005   .c 38 to 587 2 to 551   capped   550/550
(100 %)
1 diff
(99.9 %id)
DA472067   .c 39 to 783 2 to 745   capped   744/823
(90 %)
4 diff
(99.6 %id)
BM551472 melanotic melanoma, skin .c 39 to 920 1 to 886       886/1033
(85 %)
32 diff
(97.0 %id)
NM_002883.2   .c 39 to 3058 1 to 3020 exact RefSeq, AAA   3020/3020
(100 %)
0 diff
(100 %id)
BG391853 embryonal carcinoma, cell line, testis .c 40 to 776 1 to 729       729/991
(73 %)
28 diff
(97.2 %id)
BX401982   .c 53 to 543 1 to 490       490/490
(100 %)
6 diff
(98.8 %id)
CF125511 Chondrosarcoma Lung Metastasis cell lines, lung .c 53 to 330 1 to 278       278/278
(100 %)
11 diff
(96.1 %id)
CF125584 Chondrosarcoma Lung Metastasis cell lines, lung .c 53 to 691 1 to 639       639/639
(100 %)
5 diff
(99.3 %id)
TI_154187648   .c 53 to 964 136 to 1046       911/966
(94 %)
36 diff
(96.3 %id)
BP201511 amygdala .c 56 to 637 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BP214471 corpus callosum .c 57 to 638 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
DA474923   .c 57 to 611 2 to 557   capped   556/556
(100 %)
2 diff
(99.7 %id)
DB442154 testis .c 57 to 487 1 to 431       431/431
(100 %)
0 diff
(100 %id)
BP283323 bone marrow .c 57 to 639 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BP288203 lung .c 57 to 639 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
DA913649   .c 57 to 603 2 to 549   capped   548/557
(98 %)
1 diff
(99.9 %id)
DA063835 cerebellum .c 58 to 624 2 to 569   capped   568/568
(100 %)
4 diff
(99.3 %id)
DA482842   .c 58 to 635 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
DA818344   .c 58 to 610 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
DA939398 Spleen .c 58 to 646 2 to 591   capped   590/590
(100 %)
1 diff
(99.9 %id)
BX438097 neuroblastoma .c 60 to 900 1 to 840       840/840
(100 %)
2 diff
(99.8 %id)
BX446141 neuroblastoma .c 60 to 900 1 to 839       839/839
(100 %)
2 diff
(99.8 %id)
BU191873 embryonal carcinoma, cell line, testis .c 60 to 926 1 to 871       871/907
(96 %)
11 diff
(98.8 %id)
BP307967 brain .c 60 to 641 1 to 582       582/582
(100 %)
13 diff
(97.8 %id)
CN365602 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 61 to 694 1 to 637       637/637
(100 %)
5 diff
(99.3 %id)
BQ213903 embryonal carcinoma, cell line, testis .c 61 to 681 1 to 630       630/949
(66 %)
17 diff
(98.3 %id)
CX751089 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 61 to 825 22 to 772     Submitted on the opposite strand 751/790
(95 %)
40 diff
(95.0 %id)
DA791739 brain .c 61 to 613 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
CN365612 embryonic stem cells, cell lines H1, H7, andH9 .c 63 to 757 1 to 695       695/695
(100 %)
1 diff
(99.9 %id)
BX416342 neuroblastoma .c 63 to 951 1 to 883       883/883
(100 %)
15 diff
(98.4 %id)
BX417325 placenta .c 63 to 1058 1 to 983       983/995
(98 %)
20 diff
(98.0 %id)
CN482804 eye .c 63 to 200 1 to 138       138/138
(100 %)
0 diff
(100 %id)
N90379.
matches multiple genes
liver and spleen .c 63 to 415 1 to 343     also hits gene fleyty 345/372
(92 %)
23 diff
(93.9 %id)
BF981103 duodenal adenocarcinoma, cell line, small intestine .c 64 to 720 1 to 666       666/1137
(58 %)
17 diff
(98.6 %id)
CN365609 embryonic stem cells, DMSO-treated H9 cellline .c 67 to 634 1 to 569       569/569
(100 %)
2 diff
(99.7 %id)
DA012667 adrenal gland .c 68 to 638 2 to 579   capped   552/578
(95 %)
13 diff
(97.8 %id)
DA524124 brain .c 68 to 603 2 to 538   capped   537/546
(98 %)
2 diff
(99.7 %id)
BI919234 brain .c 68 to 708 28 to 683       656/683
(96 %)
24 diff
(96.5 %id)
TI_57239426   .c 68 to 708 28 to 683       656/683
(96 %)
24 diff
(96.5 %id)
DB153550 thymus .c 68 to 647 2 to 582   capped   581/581
(100 %)
1 diff
(99.9 %id)
BX446803 neuroblastoma .c 69 to 977 4 to 909       906/909
(99 %)
11 diff
(98.8 %id)
BI546018 brain, hippocampus .c 69 to 155 1 to 87       87/87
(100 %)
3 diff
(96.6 %id)
CN365604 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 70 to 376 1 to 307       307/307
(100 %)
1 diff
(99.7 %id)
BX461762 brain, fetal brain .c 70 to 1058 1 to 982       982/997
(98 %)
9 diff
(99.1 %id)
BG720524 testis .c 70 to 893 1 to 812       812/845
(96 %)
17 diff
(98.0 %id)
CN365597 embryonic stem cells, cell lines H1, H7, andH9 .c 71 to 765 1 to 697       697/697
(100 %)
5 diff
(99.3 %id)
BX410757 brain, fetal brain .c 73 to 783 1 to 716       716/874
(81 %)
18 diff
(98.0 %id)
BX419386 brain, fetal brain .c 73 to 1009 1 to 938       938/938
(100 %)
4 diff
(99.6 %id)
BG424195 Kidney, renal cell adenocarcinoma .c 73 to 754 1 to 696       696/696
(100 %)
26 diff
(96.3 %id)
CN365588 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 74 to 824 1 to 751       751/751
(100 %)
0 diff
(100 %id)
BQ217588 melanotic melanoma, skin .c 74 to 783 1 to 710       710/918
(77 %)
0 diff
(100 %id)
BP351878   .c 74 to 656 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
BF796124 lymph, lymphoma, cell line .c 76 to 846 1 to 767       767/975
(78 %)
43 diff
(95.6 %id)
BM463032 melanotic melanoma, skin .c 78 to 546 1 to 461       461/1235
(37 %)
17 diff
(98.7 %id)
CO248121 Chondrosarcoma Lung Metastasis cell lines, lung .c 78 to 751 1 to 669       669/810
(82 %)
12 diff
(98.6 %id)
AL120419 amygdala .c 79 to 524 1 to 445       445/445
(100 %)
1 diff
(99.8 %id)
BM466994 eye, retinoblastoma .c 79 to 897 21 to 848       828/1170
(70 %)
32 diff
(97.3 %id)
BQ220647 melanotic melanoma, skin .c 79 to 790 1 to 716       716/901
(79 %)
16 diff
(98.3 %id)
BQ962494 leiomyosarcoma, uterus .c 79 to 920 1 to 844       844/916
(92 %)
6 diff
(99.4 %id)
BM459022 melanotic melanoma, skin .c 80 to 894 1 to 821       821/1043
(78 %)
53 diff
(95.0 %id)
CN365600 embryonic stem cells, cell lines H1, H7, andH9 .c 81 to 677 1 to 597       597/597
(100 %)
1 diff
(99.9 %id)
TI_154196102   .c 82 to 926 21 to 862       842/1047
(80 %)
24 diff
(97.8 %id)
CN365596 embryonic stem cells, cell lines H1, H7, andH9 .c 84 to 637 1 to 554       554/554
(100 %)
0 diff
(100 %id)
BE867940 adenocarcinoma, colon .c 84 to 781 1 to 697       699/947
(73 %)
22 diff
(97.7 %id)
BC014044 Kidney, renal cell adenocarcinoma .c 85 to 3058 1 to 2974 exact tiling clone, available from MGC, AAA   2974/2974
(100 %)
2 diff
(100.0 %id)
BX428293 brain, fetal brain .c 85 to 1058 17 to 981       965/1092
(88 %)
16 diff
(98.6 %id)
BX461451 brain, fetal brain .c 85 to 1028 17 to 960       944/960
(98 %)
6 diff
(99.4 %id)
BF982830 duodenal adenocarcinoma, cell line, small intestine .c 85 to 790 1 to 701       701/914
(76 %)
12 diff
(98.7 %id)
BF984963 duodenal adenocarcinoma, cell line, small intestine .c 95 to 783 1 to 688       688/911
(75 %)
9 diff
(99.1 %id)
BI093441 cervix .c 96 to 873 1 to 777       777/778
(99 %)
16 diff
(98.0 %id)
BE783556 eye, retinoblastoma .c 103 to 880 1 to 767       767/767
(100 %)
66 diff
(91.4 %id)
CN365590 embryonic stem cells, cell lines H1, H7, andH9 .c 118 to 494 1 to 377       377/377
(100 %)
2 diff
(99.5 %id)
CO249763 Chondrosarcoma Lung Metastasis cell lines, lung .c 120 to 781 1 to 658       658/815
(80 %)
10 diff
(98.8 %id)
CN365595 embryonic stem cells, cell lines H1, H7, andH9 .c 134 to 611 1 to 478       478/478
(100 %)
0 diff
(100 %id)
BX407335 neuroblastoma .c 134 to 900 760 to 1       760/825
(92 %)
19 diff
(97.7 %id)
CN365586 embryonic stem cells, cell lines H1, H7, andH9 .c 136 to 839 1 to 704       704/704
(100 %)
0 diff
(100 %id)
AA852745 Bone, Hip .c 136 to 439 1 to 300       303/300
(101 %)
11 diff
(96.4 %id)
DA198926 brain .c 197 to 772 2 to 577   capped   576/576
(100 %)
2 diff
(99.7 %id)
BG576027 breast, mammary adenocarcinoma, cell line .c 270 to 1077 1 to 808       808/821
(98 %)
15 diff
(98.2 %id)
BE793169 lung, small cell carcinoma .c 277 to 1076 1 to 794       794/959
(82 %)
16 diff
(98.4 %id)
BU172655 melanotic melanoma, skin .c 296 to 1072 1 to 781       781/887
(88 %)
10 diff
(98.9 %id)
TI_1948139356   .c 297 to 1074 111 to 890       780/1310
(59 %)
22 diff
(98.4 %id)
TI_1948139606   .c 297 to 1076 115 to 903       789/1392
(56 %)
24 diff
(98.3 %id)
TI_1948139849   .c 297 to 1076 116 to 898       783/1310
(59 %)
22 diff
(98.4 %id)
TI_1948139850   .c 297 to 1074 119 to 895       777/1292
(60 %)
14 diff
(99.0 %id)
TI_1948140111   .c 297 to 1077 119 to 899       781/1331
(58 %)
18 diff
(98.7 %id)
TI_1948140112   .c 297 to 1196 121 to 1023       903/1304
(69 %)
43 diff
(96.8 %id)
CU013445 Synthetic constructs .c 300 to 2070 16 to 1786 exact     1771/1795
(98 %)
11 diff
(99.4 %id)
CU013157 Synthetic constructs .c 300 to 2067 16 to 1783 exact     1768/1798
(98 %)
8 diff
(99.6 %id)
CV028480 mixed .c 304 to 833 1 to 530       530/530
(100 %)
0 diff
(100 %id)
X82260   .c 304 to 2067 1 to 1764 exact     1764/1764
(100 %)
2 diff
(99.9 %id)
BM913399 amelanotic melanoma, cell line, skin .c 311 to 1195 20 to 908       889/1046
(84 %)
17 diff
(98.4 %id)
BM009177 amelanotic melanoma, cell line, skin .c 315 to 1201 1 to 892       892/910
(98 %)
23 diff
(97.5 %id)
BM009761 amelanotic melanoma, cell line, skin .c 315 to 1124 1 to 810       810/810
(100 %)
10 diff
(98.8 %id)
BM010720 amelanotic melanoma, cell line, skin .c 315 to 1134 1 to 828       735/831
(88 %)
25 diff
(97.0 %id)
TI_59383894   .c 316 to 1201 61 to 951       891/909
(98 %)
22 diff
(97.6 %id)
TI_59384532   .c 316 to 1124 61 to 869       809/809
(100 %)
9 diff
(98.9 %id)
TI_59385566   .c 316 to 1134 63 to 889       827/830
(99 %)
26 diff
(96.9 %id)
CR985279 T-Lymphocytes .c 352 to 1192 1 to 843       843/859
(98 %)
3 diff
(99.7 %id)
CN365607 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 354 to 1050 1 to 696       696/696
(100 %)
1 diff
(99.9 %id)
BM904795 melanotic melanoma, skin .c 371 to 1291 1 to 920       920/965
(95 %)
4 diff
(99.6 %id)
BG761480 melanotic melanoma, high MDR (cell line), skin .c 398 to 1108 1 to 711       711/711
(100 %)
1 diff
(99.9 %id)
DB022354 testis .c 401 to 966 2 to 567   capped   566/566
(100 %)
2 diff
(99.7 %id)
CR994181 T-Lymphocytes .c 415 to 1127 1 to 716       714/716
(99 %)
8 diff
(98.9 %id)
DB059273 testis .c 421 to 961 2 to 542   capped   541/541
(100 %)
0 diff
(100 %id)
DA141864 alzheimer cortex .c 423 to 965 2 to 545   capped   544/544
(100 %)
2 diff
(99.7 %id)
BX449426 neuroblastoma .c 431 to 1233 2 to 797       796/843
(94 %)
22 diff
(97.4 %id)
BE304394 adenocarcinoma cell line, colon .c 478 to 1192 1 to 716       714/758
(94 %)
18 diff
(97.7 %id)
BE206764 lung, small cell carcinoma .c 501 to 1154 1 to 654       654/654
(100 %)
4 diff
(99.4 %id)
BG913126 anaplastic oligodendroglioma with 1p/19qloss, brain .c 510 to 1254 1 to 746       746/747
(99 %)
15 diff
(98.0 %id)
TI_154197492   .c 516 to 1163 51 to 700       650/974
(66 %)
30 diff
(97.0 %id)
BF034775 adenocarcinoma, ovary .c 517 to 1174 1 to 659       659/659
(100 %)
1 diff
(99.9 %id)
TI_154195860   .c 521 to 1371 24 to 869       846/1048
(80 %)
23 diff
(97.9 %id)
H55068   .c 544 to 603 1 to 60       60/60
(100 %)
0 diff
(100 %id)
BG104784 adrenal cortex carcinoma, cell line, adrenal gland .c 557 to 1226 1 to 668       668/668
(100 %)
6 diff
(99.2 %id)
BI196744 brain, neuroblastoma .c 621 to 1332 1 to 711       711/711
(100 %)
7 diff
(99.1 %id)
BG397055 melanotic melanoma, skin .c 623 to 1292 1 to 667       667/830
(80 %)
7 diff
(99.2 %id)
CO247387 Chondrosarcoma Lung Metastasis cell lines, lung .c 625 to 1373 1 to 740       740/835
(88 %)
19 diff
(97.8 %id)
BQ431750 melanotic melanoma, skin .c 631 to 1469 1 to 840       840/883
(95 %)
17 diff
(98.1 %id)
DR761320 embryonic stem .c 667 to 1404 1 to 738       738/738
(100 %)
1 diff
(99.9 %id)
BE386030 melanotic melanoma, skin .c 670 to 1343 1 to 670       670/670
(100 %)
4 diff
(99.5 %id)
BF026047 melanotic melanoma, skin .c 671 to 1292 1 to 621       621/624
(99 %)
3 diff
(99.6 %id)
CR997636 T-Lymphocytes .c 678 to 1208 1 to 532       532/532
(100 %)
1 diff
(99.9 %id)
BX428397 placenta .c 717 to 1416 1 to 703       703/747
(94 %)
13 diff
(98.3 %id)
BE276427 melanotic melanoma, skin .c 736 to 1230 1 to 498       496/498
(99 %)
4 diff
(99.2 %id)
BM551464 melanotic melanoma, skin .c 748 to 1729 1 to 991       991/1027
(96 %)
19 diff
(98.2 %id)
BX407237 brain, fetal brain .c 824 to 1467 38 to 678       641/687
(93 %)
21 diff
(97.0 %id)
CU443891 epidermis .c 847 to 1478 640 to 9     Submitted on the opposite strand 632/640
(98 %)
0 diff
(100 %id)
BX430573 placenta .c 880 to 1376 1 to 497       497/497
(100 %)
4 diff
(99.2 %id)
TI_59381903   .c 898 to 1403 106 to 614   AAA   509/915
(55 %)
8 diff
(99.2 %id)
CX868796 embryonic stem .c 920 to 1696 1 to 777       777/777
(100 %)
0 diff
(100 %id)
BQ637548 eye, retina .c 933 to 1411 1 to 479       479/479
(100 %)
1 diff
(99.8 %id)
BE392619 endometrium, adenocarcinoma cell line, uterus .c 946 to 1511 1 to 565       565/565
(100 %)
1 diff
(99.9 %id)
BM020992 astrocytoma grade IV, cell line, brain .c 1019 to 1768 1 to 754       754/754
(100 %)
15 diff
(98.1 %id)
TI_59389110   .c 1019 to 1768 109 to 862       754/754
(100 %)
15 diff
(98.1 %id)
BQ683196 melanotic melanoma, cell line, skin .c 1032 to 1782 1 to 754       754/924
(81 %)
22 diff
(97.7 %id)
BM554861 duodenal adenocarcinoma, cell line, small intestine .c 1051 to 1997 29 to 985       957/1095
(87 %)
43 diff
(96.1 %id)
BQ422305 melanotic melanoma, skin .c 1074 to 1786 1 to 718       717/917
(78 %)
19 diff
(98.0 %id)
BQ684706 ductal carcinoma, cell line, Pancreas .c 1095 to 1875 1 to 783       783/919
(85 %)
10 diff
(99.0 %id)
BE254157 eye, retinoblastoma .c 1104 to 1580 1 to 477       477/479
(99 %)
1 diff
(99.8 %id)
BE893451 melanotic melanoma, skin .c 1129 to 1785 1 to 657       657/976
(67 %)
6 diff
(99.4 %id)
BQ053784 blood, natural killer cells, cell line .c 1148 to 2098 1 to 968       966/976
(98 %)
32 diff
(96.8 %id)
BX403550 placenta .c 1165 to 2202 1 to 1028       1028/1094
(93 %)
20 diff
(98.2 %id)
BG029913 breast, mammary adenocarcinoma, cell line .c 1222 to 1879 1 to 658       658/951
(69 %)
7 diff
(99.3 %id)
CV814127 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 1234 to 1957 1 to 724       724/724
(100 %)
4 diff
(99.5 %id)
AW249229 lung, small cell carcinoma .c 1272 to 1704 8 to 440       433/440
(98 %)
6 diff
(98.7 %id)
CN365592 embryonic stem cells, cell lines H1, H7, andH9 .c 1330 to 1976 1 to 647       647/647
(100 %)
1 diff
(99.9 %id)
BE621295 epithelioid carcinoma, Pancreas .c 1332 to 1938 1 to 606       606/606
(100 %)
2 diff
(99.7 %id)
CN365591 embryonic stem cells, DMSO-treated H9 cellline .c 1335 to 1839 1 to 505       505/505
(100 %)
3 diff
(99.5 %id)
BQ226172 melanotic melanoma, skin .c 1353 to 2213 23 to 892       870/902
(96 %)
29 diff
(96.8 %id)
BQ218682 epithelioid carcinoma, Pancreas .c 1361 to 2173 1 to 827       827/849
(97 %)
23 diff
(97.3 %id)
TI_59386677   .c 1402 to 2045 88 to 739       652/775
(84 %)
14 diff
(98.2 %id)
BM008968 adenocarcinoma, Pancreas .c 1405 to 2045 1 to 649       649/772
(84 %)
14 diff
(98.2 %id)
BX451026 brain, fetal brain .c 1412 to 2177 772 to 1       772/888
(86 %)
53 diff
(94.1 %id)
EB385482 eye, optic nerve .c 1412 to 2177 1 to 766       766/766
(100 %)
1 diff
(99.9 %id)
BM853481 Ascites, stomach .c 1419 to 1943 1 to 525       525/525
(100 %)
2 diff
(99.7 %id)
BG327933 Kidney, renal cell adenocarcinoma .c 1424 to 2180 1 to 749       749/751
(99 %)
16 diff
(97.9 %id)
BC004990 Skin, melanotic melanoma. .c 1425 to 3060 1 to 1636   tiling clone, available from MGC, AAA   1636/1636
(100 %)
1 diff
(100.0 %id)
BG115069 duodenal adenocarcinoma, cell line, small intestine .c 1425 to 2140 53 to 756       708/925
(76 %)
16 diff
(98.3 %id)
BM795078 Ascites, stomach .c 1425 to 1979 1 to 555       555/555
(100 %)
4 diff
(99.3 %id)
BM010161 amelanotic melanoma, cell line, skin .c 1427 to 2137 1 to 714       714/714
(100 %)
6 diff
(99.2 %id)
BM553423 amelanotic melanoma, cell line, skin .c 1428 to 2383 1 to 962       962/1119
(85 %)
10 diff
(99.2 %id)
BM555837 amelanotic melanoma, cell line, skin .c 1428 to 2341 1 to 923       923/1172
(78 %)
25 diff
(97.9 %id)
BM550926 amelanotic melanoma, cell line, skin .c 1428 to 2477 1 to 1058       1058/1063
(99 %)
29 diff
(97.3 %id)
BM559416 amelanotic melanoma, cell line, skin .c 1428 to 2364 1 to 944       944/1001
(94 %)
16 diff
(98.5 %id)
BM558869 amelanotic melanoma, cell line, skin .c 1428 to 2420 1 to 1004       1004/1054
(95 %)
23 diff
(97.9 %id)
TI_59383799   .c 1428 to 1998 62 to 637       576/676
(85 %)
14 diff
(98.0 %id)
TI_59384960   .c 1428 to 2137 98 to 810       713/713
(100 %)
5 diff
(99.3 %id)
BG767373 melanotic melanoma, high MDR (cell line), skin .c 1430 to 2083 1 to 655       655/655
(100 %)
6 diff
(99.1 %id)
BM564183 blood, natural killer cells, cell line .c 1431 to 2283 1 to 854       854/1131
(75 %)
29 diff
(97.5 %id)
BQ231561 embryonal carcinoma, cell line, testis .c 1431 to 2237 1 to 814       814/941
(86 %)
14 diff
(98.6 %id)
CD300172 testis .c 1431 to 2294 1 to 865       865/868
(99 %)
9 diff
(99.0 %id)
CR595421 thymus .c 1432 to 3028 1 to 1597       1597/1597
(100 %)
0 diff
(100 %id)
BX456992 thymus .c 1432 to 2176 1 to 744   fully sequenced,   744/744
(100 %)
6 diff
(99.2 %id)
BQ060789 lymph, lymphoma, cell line .c 1433 to 2203 1 to 783       783/1043
(75 %)
22 diff
(97.9 %id)
CX165540 human embryonic stem cells differentiated toan early endodermal cell type .c 1433 to 2234 1 to 802       802/802
(100 %)
1 diff
(99.9 %id)
BM456302 lymph, lymphoma, cell line .c 1434 to 2242 1 to 812       812/861
(94 %)
10 diff
(98.9 %id)
BQ071065 brain, neuroblastoma, cell line .c 1434 to 2237 1 to 805       805/1007
(79 %)
20 diff
(98.1 %id)
BI117407 lung, small cell carcinoma .c 1444 to 2171 1 to 728       728/1071
(67 %)
16 diff
(98.6 %id)
CR991417 T-Lymphocytes .c 1444 to 2113 1 to 672       672/672
(100 %)
4 diff
(99.5 %id)
BU188376 melanotic melanoma, skin .c 1445 to 2313 1 to 875       875/886
(98 %)
10 diff
(98.9 %id)
BE897365 melanotic melanoma, skin .c 1450 to 2158 1 to 706       706/706
(100 %)
9 diff
(98.8 %id)
BQ221121 embryonal carcinoma, cell line, testis .c 1461 to 2304 1 to 848       848/849
(99 %)
10 diff
(98.9 %id)
BU172755 melanotic melanoma, skin .c 1471 to 2190 12 to 738       727/958
(75 %)
19 diff
(98.1 %id)
TI_1948139851   .c 1471 to 2066 724 to 123       602/1317
(45 %)
13 diff
(99.1 %id)
FN082434 breast carcinoma .c 1473 to 1541 69 to 1     Submitted on the opposite strand 69/69
(100 %)
0 diff
(100 %id)
BG386012 adenocarcinoma cell line, colon .c 1475 to 2334 1 to 855       855/879
(97 %)
33 diff
(96.3 %id)
BM542955 embryonal carcinoma, cell line, testis .c 1477 to 2489 1 to 1039       1039/1090
(95 %)
52 diff
(95.3 %id)
BE386261 melanotic melanoma, skin .c 1481 to 2212 1 to 734       734/765
(95 %)
14 diff
(98.2 %id)
BE729240 melanotic melanoma, skin .c 1483 to 2168 1 to 686       686/686
(100 %)
0 diff
(100 %id)
AW250127 lung, small cell carcinoma .c 1485 to 2047 5 to 567       563/567
(99 %)
6 diff
(99.0 %id)
BQ056013 lymph, lymphoma, cell line .c 1485 to 2367 1 to 892       892/1013
(88 %)
33 diff
(96.8 %id)
BQ644726 hepatocellular carcinoma, cell line, Liver .c 1487 to 2234 1 to 752       752/997
(75 %)
22 diff
(97.8 %id)
BQ646223 hepatocellular carcinoma, cell line, Liver .c 1487 to 2333 1 to 853       853/912
(93 %)
12 diff
(98.7 %id)
BG753701 eye, normal pigmented retinal epithelium .c 1488 to 2237 1 to 756       756/911
(82 %)
20 diff
(97.9 %id)
BM917788 blood, natural killer cells, cell line .c 1489 to 2329 18 to 864       847/1052
(80 %)
21 diff
(98.1 %id)
BF316616 brain, neuroblastoma .c 1494 to 2240 1 to 742       742/964
(76 %)
16 diff
(98.4 %id)
BF317337 brain, neuroblastoma .c 1494 to 2249 1 to 754       754/1169
(64 %)
12 diff
(99.0 %id)
BI196126 brain, neuroblastoma .c 1494 to 2223 1 to 730       730/731
(99 %)
5 diff
(99.4 %id)
BQ650047 hepatocellular carcinoma, cell line, Liver .c 1494 to 2213 21 to 742       722/874
(82 %)
19 diff
(97.9 %id)
BQ644469 hepatocellular carcinoma, cell line, Liver .c 1494 to 2275 65 to 857       793/982
(80 %)
23 diff
(97.7 %id)
BG420121 Kidney, renal cell adenocarcinoma .c 1495 to 2202 1 to 712       712/984
(72 %)
11 diff
(98.9 %id)
BG490947 large cell carcinoma, lung .c 1495 to 2323 1 to 831       831/833
(99 %)
17 diff
(98.0 %id)
BU542246 carcinoma, cell line, Prostate .c 1500 to 2370 1 to 879       879/880
(99 %)
11 diff
(98.8 %id)
AA351030 brain .c 1501 to 1834 1 to 334       334/334
(100 %)
0 diff
(100 %id)
BE389322 endometrium, adenocarcinoma cell line, uterus .c 1502 to 2188 1 to 688       688/689
(99 %)
13 diff
(98.2 %id)
BX428587 placenta .c 1504 to 2342 825 to 1       825/923
(89 %)
32 diff
(96.6 %id)
BE798636 lung, small cell carcinoma .c 1510 to 2322 1 to 811       811/887
(91 %)
10 diff
(98.9 %id)
TI_153975876   .c 1511 to 2087 78 to 653       576/577
(99 %)
11 diff
(98.1 %id)
BE313596 brain, neuroblastoma .c 1514 to 1985 1 to 474       474/474
(100 %)
3 diff
(99.4 %id)
BE729514 melanotic melanoma, skin .c 1516 to 2282 1 to 759       759/965
(78 %)
14 diff
(98.6 %id)
TI_154128164   .c 1516 to 2372 932 to 80   AAA   853/1003
(85 %)
8 diff
(99.3 %id)
CN365608 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 1518 to 2057 7 to 546       540/546
(98 %)
1 diff
(99.9 %id)
BF345488 anaplastic oligodendroglioma with 1p/19qloss, brain .c 1521 to 2292 1 to 766       766/1069
(71 %)
10 diff
(99.1 %id)
BU190935 ductal carcinoma, cell line, Pancreas .c 1529 to 2298 1 to 786       786/830
(94 %)
34 diff
(96.0 %id)
BU163000 ductal carcinoma, cell line, Pancreas .c 1529 to 2453 1 to 932       932/975
(95 %)
27 diff
(97.3 %id)
BQ687185 ductal carcinoma, cell line, Pancreas .c 1529 to 2386 1 to 871       871/893
(97 %)
19 diff
(97.9 %id)
BQ685176 ductal carcinoma, cell line, Pancreas .c 1529 to 2278 1 to 755       755/794
(95 %)
9 diff
(98.9 %id)
BF311117 brain, neuroblastoma .c 1538 to 2282 1 to 741       741/793
(93 %)
15 diff
(98.2 %id)
BG760701 melanotic melanoma, high MDR (cell line), skin .c 1538 to 2477 1 to 923       923/936
(98 %)
34 diff
(96.4 %id)
BG763426 melanotic melanoma, high MDR (cell line), skin .c 1538 to 2256 1 to 720       720/721
(99 %)
3 diff
(99.6 %id)
BG763746 melanotic melanoma, high MDR (cell line), skin .c 1538 to 2190 1 to 653       653/653
(100 %)
1 diff
(99.9 %id)
BG765600 melanotic melanoma, high MDR (cell line), skin .c 1538 to 2231 1 to 696       696/696
(100 %)
8 diff
(98.9 %id)
BQ061240 lymph, lymphoma, cell line .c 1539 to 2449 1 to 927       927/1058
(87 %)
23 diff
(97.9 %id)
BQ641923 lymph, lymphoma, cell line .c 1539 to 2423 1 to 898       898/918
(97 %)
18 diff
(98.1 %id)
BX360285 Placenta Cot 25-normalized .c 1557 to 2167 1 to 601   fully sequenced,   601/601
(100 %)
7 diff
(98.9 %id)
BE388952 endometrium, adenocarcinoma cell line, uterus .c 1558 to 2215 1 to 659       659/663
(99 %)
6 diff
(99.1 %id)
BE261853 brain, neuroblastoma .c 1559 to 2223 1 to 661       661/661
(100 %)
9 diff
(98.7 %id)
BX428603 brain, fetal brain .c 1563 to 2300 743 to 10       734/864
(84 %)
23 diff
(97.4 %id)
TI_1948140113   .c 1563 to 2066 634 to 129       506/1277
(39 %)
22 diff
(98.3 %id)
BG333900 melanotic melanoma, skin .c 1577 to 2252 1 to 676       676/898
(75 %)
13 diff
(98.6 %id)
BE384614 melanotic melanoma, skin .c 1597 to 2179 1 to 583       583/584
(99 %)
1 diff
(99.9 %id)
BQ421311 embryonal carcinoma, cell line, testis .c 1605 to 2460 1 to 861       861/861
(100 %)
9 diff
(99.0 %id)
CA417394 Chondrosarcoma Cell line .c 1611 to 2372 778 to 19   AAA   760/760
(100 %)
3 diff
(99.7 %id)
BU552902 ovary, teratocarcinoma, cell line .c 1662 to 2549 1 to 895       895/896
(99 %)
14 diff
(98.5 %id)
BX428611 brain, fetal brain .c 1681 to 2549 890 to 20       871/890
(97 %)
12 diff
(98.7 %id)
TI_154035892   .c 1683 to 2372 782 to 92   AAA   691/803
(86 %)
22 diff
(97.3 %id)
BG742980 skin .c 1687 to 2513 1 to 825       825/829
(99 %)
12 diff
(98.6 %id)
BE782622 eye, retinoblastoma .c 1701 to 2449 1 to 740       740/780
(94 %)
18 diff
(97.7 %id)
BQ722881 sympathetic trunk .c 1714 to 2381 1 to 670       670/973
(68 %)
14 diff
(98.6 %id)
BQ424369 eye, retinoblastoma .c 1733 to 2457 1 to 743       743/802
(92 %)
15 diff
(98.2 %id)
BE388473 endometrium, adenocarcinoma cell line, uterus .c 1742 to 2351 1 to 608       608/611
(99 %)
4 diff
(99.4 %id)
BG677309 skin, squamous cell carcinoma .c 1753 to 2572 1 to 815       815/817
(99 %)
13 diff
(98.5 %id)
BM043625 carcinoma, cell line, Prostate .c 1762 to 2488 1 to 722       722/723
(99 %)
11 diff
(98.5 %id)
BM047792 carcinoma, cell line, Prostate .c 1762 to 2499 1 to 741       741/765
(96 %)
14 diff
(98.2 %id)
BQ887514 carcinoma, cell line, Prostate .c 1764 to 2671 1 to 909       909/911
(99 %)
18 diff
(98.1 %id)
TI_59386914   .c 1767 to 2496 107 to 823       717/830
(86 %)
34 diff
(96.0 %id)
TI_59389216   .c 1767 to 2541 103 to 877       775/775
(100 %)
6 diff
(99.3 %id)
BM018554 astrocytoma grade IV, cell line, brain .c 1768 to 2541 1 to 774       774/774
(100 %)
6 diff
(99.3 %id)
BI754948 brain .c 1773 to 2525 1 to 755       755/757
(99 %)
8 diff
(99.0 %id)
BU164870 eye, retinoblastoma .c 1773 to 2643 1 to 874       874/909
(96 %)
18 diff
(98.1 %id)
TI_59394111   .c 1776 to 2573 86 to 885       800/800
(100 %)
9 diff
(98.9 %id)
BX407331 neuroblastoma .c 1785 to 2615 827 to 1       827/1042
(79 %)
12 diff
(98.9 %id)
TI_57218346   .c 1785 to 2525 45 to 787       743/789
(94 %)
12 diff
(98.5 %id)
CN365598 embryonic stem cells, cell lines H1, H7, andH9 .c 1788 to 2453 1 to 666       666/666
(100 %)
3 diff
(99.6 %id)
BM698620 eye, fetal eyes .c 1803 to 2360 1 to 559       559/559
(100 %)
2 diff
(99.7 %id)
BG281138 melanotic melanoma, skin .c 1814 to 2694 1 to 882       882/975
(90 %)
37 diff
(96.3 %id)
H46148 brain .c 1816 to 2137 1 to 324       324/447
(72 %)
4 diff
(99.2 %id)
CD615953   .c 1823 to 2420 598 to 1       598/611
(97 %)
3 diff
(99.6 %id)
BP430407   .c 1843 to 2262 1 to 420       420/420
(100 %)
4 diff
(99.1 %id)
BP430408   .c 1843 to 2258 1 to 416       416/416
(100 %)
4 diff
(99.1 %id)
BP430417   .c 1843 to 2259 1 to 417       417/417
(100 %)
4 diff
(99.1 %id)
BP430418   .c 1843 to 2265 1 to 423       423/423
(100 %)
4 diff
(99.1 %id)
BP430427   .c 1843 to 2260 1 to 418       418/418
(100 %)
4 diff
(99.1 %id)
BP430428   .c 1844 to 2259 1 to 416       416/416
(100 %)
3 diff
(99.3 %id)
CN365593 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 1852 to 2315 1 to 464       464/464
(100 %)
0 diff
(100 %id)
BP430437   .c 1873 to 2241 1 to 369       369/369
(100 %)
0 diff
(100 %id)
TI_159677457   .c 1873 to 2687 45 to 860       820/1083
(75 %)
12 diff
(98.9 %id)
TI_153990494   .c 1874 to 2372 575 to 77   AAA   499/878
(56 %)
1 diff
(99.9 %id)
TI_154171521   .c 1875 to 2379 80 to 587       508/1023
(49 %)
11 diff
(99.0 %id)
BM794170 Ascites, stomach .c 1881 to 2436 1 to 556       556/556
(100 %)
3 diff
(99.5 %id)
BM718650 eye, fetal eye .c 1882 to 2570 1 to 689   fully sequenced,   689/689
(100 %)
0 diff
(100 %id)
BC019676 Bladder, transitional cell papilloma .c 1884 to 3056 1 to 1173   available from MGC, AAA   1173/1173
(100 %)
1 diff
(100.0 %id)
BG423825 Kidney, renal cell adenocarcinoma .c 1886 to 2619 1 to 726       726/955
(76 %)
16 diff
(98.4 %id)
BP430397   .c 1893 to 2245 1 to 353       353/353
(100 %)
0 diff
(100 %id)
BX461761 brain, fetal brain .c 1896 to 3003 1110 to 15       1096/1110
(98 %)
11 diff
(99.1 %id)
AI139769   .c 1906 to 2373 470 to 3       468/470
(99 %)
0 diff
(100 %id)
CA444166 Fibrosarcoma .c 1908 to 2372 484 to 19   AAA   466/466
(100 %)
1 diff
(99.8 %id)
BG419602 Kidney, renal cell adenocarcinoma .c 1921 to 2572 1 to 653       653/653
(100 %)
8 diff
(98.8 %id)
CX164912 human embryonic stem cells differentiated toan early endodermal cell type .c 1921 to 2648 1 to 727       727/727
(100 %)
1 diff
(99.9 %id)
CA337643 1st pharyngeal arch (pooled) .c 1923 to 2372 1 to 449   AAA   449/449
(100 %)
3 diff
(99.4 %id)
H17609 whole brain .c 1931 to 2337 1 to 418       418/423
(98 %)
19 diff
(95.6 %id)
BE743930 adenocarcinoma cell line, ovary .c 1932 to 2769 1 to 842       842/851
(98 %)
24 diff
(97.2 %id)
EL955295 eyeball .c 1935 to 2542 7 to 613       607/613
(99 %)
5 diff
(99.2 %id)
TI_151773699   .c 1947 to 2596 109 to 762       654/968
(67 %)
6 diff
(99.4 %id)
BG742020 skin .c 1978 to 2857 1 to 878       878/918
(95 %)
17 diff
(98.2 %id)
BG743242 skin .c 1978 to 2925 1 to 957       957/1000
(95 %)
22 diff
(97.8 %id)
BX428292 brain, fetal brain .c 1989 to 3042 1047 to 1       1047/1133
(92 %)
24 diff
(97.9 %id)
BM694126 eye, RPE and Choroid .c 1990 to 2375 1 to 386       386/386
(100 %)
0 diff
(100 %id)
BX461739 brain, fetal brain .c 1998 to 3032 1035 to 1       1035/1035
(100 %)
13 diff
(98.8 %id)
CN365587 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 2001 to 2540 1 to 540       540/540
(100 %)
4 diff
(99.3 %id)
AA852746 Bone, Hip .c 2046 to 2338 299 to 8       292/299
(97 %)
0 diff
(100 %id)
BU556860 ovary, teratocarcinoma, cell line .c 2076 to 2910 1 to 840   AAA   840/933
(90 %)
22 diff
(97.7 %id)
BI859368 breast, mammary adenocarcinoma, cell line .c 2088 to 2906 1 to 820       820/820
(100 %)
15 diff
(98.2 %id)
TI_57190840   .c 2088 to 2906 55 to 874       820/820
(100 %)
15 diff
(98.2 %id)
BM711922 eye, human retina .c 2093 to 2617 1 to 525   fully sequenced,   525/525
(100 %)
0 diff
(100 %id)
TI_149311486   .c 2105 to 3058 1038 to 86   AAA   953/974
(97 %)
25 diff
(97.5 %id)
BM698913 eye, fetal eyes .c 2118 to 2582 1 to 465   fully sequenced,   465/465
(100 %)
1 diff
(99.8 %id)
BG754856 B-cells, primary B-cells from tonsils (cell line) .c 2120 to 2961 1 to 845       845/849
(99 %)
12 diff
(98.6 %id)
BX360284 Placenta Cot 25-normalized .c 2137 to 3013 895 to 19   fully sequenced,   877/895
(97 %)
5 diff
(99.5 %id)
R88458 brain .c 2144 to 2528 23 to 412       390/449
(86 %)
16 diff
(96.5 %id)
BX456991 thymus .c 2146 to 3028 881 to 1   fully sequenced,   881/881
(100 %)
6 diff
(99.4 %id)
BU538851 adenocarcinoma, cell line, breast .c 2148 to 2997 1 to 864       864/912
(94 %)
21 diff
(97.7 %id)
BU538875 adenocarcinoma, cell line, breast .c 2148 to 3000 1 to 866       866/894
(96 %)
27 diff
(97.0 %id)
BU538912 adenocarcinoma, cell line, breast .c 2148 to 3029 1 to 887       887/889
(99 %)
15 diff
(98.4 %id)
BU538977 adenocarcinoma, cell line, breast .c 2148 to 2927 1 to 785       785/932
(84 %)
13 diff
(98.7 %id)
BU856743 adenocarcinoma, cell line, breast .c 2148 to 2993 1 to 858       858/891
(96 %)
20 diff
(97.8 %id)
CR597202 Placenta Cot 25-normalized .c 2178 to 3059 1 to 882       882/882
(100 %)
0 diff
(100 %id)
BX361344 Placenta Cot 25-normalized .c 2178 to 3059 1 to 881       881/881
(100 %)
12 diff
(98.7 %id)
AW731906 lung, small cell carcinoma .c 2193 to 2373 183 to 3       181/183
(98 %)
0 diff
(100 %id)
BQ682655 melanotic melanoma, cell line, skin .c 2195 to 3062 1 to 882   AAA   882/941
(93 %)
32 diff
(96.6 %id)
BG166643 hypernephroma, cell line, Kidney .c 2203 to 2970 1 to 764       764/775
(98 %)
24 diff
(97.0 %id)
BM046950 carcinoma, cell line, Prostate .c 2212 to 2956 1 to 744       744/744
(100 %)
7 diff
(99.1 %id)
BM047080 carcinoma, cell line, Prostate .c 2212 to 2936 1 to 730       730/730
(100 %)
15 diff
(98.0 %id)
TI_149287996   .c 2224 to 3058 918 to 95   AAA   824/995
(82 %)
22 diff
(97.8 %id)
BQ440086 melanotic melanoma, skin .c 2225 to 3010 12 to 801       790/881
(89 %)
6 diff
(99.4 %id)
BG491199 amelanotic melanoma, cell line, skin .c 2226 to 2660 1 to 436   fully sequenced,   436/436
(100 %)
2 diff
(99.6 %id)
BM556485 amelanotic melanoma, cell line, skin .c 2227 to 2915 27 to 715       689/1086
(63 %)
15 diff
(98.7 %id)
BM550690 amelanotic melanoma, cell line, skin .c 2227 to 3057 1 to 834       834/1087
(76 %)
12 diff
(98.9 %id)
BM809414 amelanotic melanoma, cell line, skin .c 2228 to 2997 1 to 777       777/1156
(67 %)
20 diff
(98.3 %id)
BE379408 endometrium, adenocarcinoma cell line, uterus .c 2239 to 3071 40 to 873       834/976
(85 %)
17 diff
(98.3 %id)
TI_154101973   .c 2277 to 3060 830 to 54   AAA   777/936
(83 %)
11 diff
(98.9 %id)
H18150 brain .c 2279 to 2697 1 to 432   fully sequenced,   432/432
(100 %)
31 diff
(92.9 %id)
BM709373 eye, optic nerve .c 2283 to 2554 1 to 272   fully sequenced,   272/272
(100 %)
1 diff
(99.7 %id)
AA486455 ovarian tumor, ovary .c 2318 to 2728 1 to 408   fully sequenced,   408/408
(100 %)
5 diff
(98.8 %id)
BU526962 epidermoid carcinoma, cell line, lung .c 2327 to 3058 1 to 732       732/733
(99 %)
2 diff
(99.8 %id)
TI_154128602   .c 2328 to 3058 816 to 95   AAA   722/726
(99 %)
21 diff
(97.2 %id)
BI759458 pooled colon, kidney, stomach .c 2335 to 3005 1 to 672       672/672
(100 %)
1 diff
(99.9 %id)
TI_57149461   .c 2335 to 3005 30 to 701       672/701
(95 %)
6 diff
(99.2 %id)
BQ424384 melanotic melanoma, skin .c 2337 to 3064 1 to 728       728/867
(83 %)
5 diff
(99.5 %id)
BM977386 lung, Primary Lung Cystic Fibrosis EpithelialCells .c 2340 to 3058 742 to 19   AAA   724/724
(100 %)
6 diff
(99.2 %id)
BG491420 amelanotic melanoma, cell line, skin .c 2341 to 3057 1 to 716   AAA   716/716
(100 %)
6 diff
(99.2 %id)
BM911800 amelanotic melanoma, cell line, skin .c 2343 to 3050 1 to 712       712/1026
(69 %)
14 diff
(98.7 %id)
BM810912 amelanotic melanoma, cell line, skin .c 2343 to 3058 1 to 717   AAA   717/717
(100 %)
1 diff
(99.9 %id)
CA445339 Chondrosarcoma, Left Pubic Bone .c 2343 to 3060 732 to 17   AAA   716/716
(100 %)
2 diff
(99.8 %id)
BE798512 lung, small cell carcinoma .c 2360 to 3066 39 to 755       717/849
(84 %)
14 diff
(98.4 %id)
BE892243 melanotic melanoma, skin .c 2361 to 2979 1 to 619       619/619
(100 %)
2 diff
(99.7 %id)
BX455162 brain, fetal brain .c 2363 to 3056 700 to 1       700/917
(76 %)
26 diff
(97.2 %id)
CR997113 T-Lymphocytes .c 2371 to 2910 1 to 541       541/541
(100 %)
4 diff
(99.3 %id)
BU194287 melanotic melanoma, skin .c 2376 to 3060 1 to 685   AAA   685/685
(100 %)
0 diff
(100 %id)
TI_151707861   .c 2387 to 3057 815 to 149   AAA   667/669
(99 %)
32 diff
(95.3 %id)
BQ772731 Chondrosarcoma Cell line .c 2388 to 3062 691 to 17   AAA   675/675
(100 %)
1 diff
(99.9 %id)
BQ027108 Chondrosarcoma, Left Pubic Bone .c 2389 to 3058 688 to 19   AAA   670/670
(100 %)
1 diff
(99.9 %id)
BQ000147 Fibrosarcoma .c 2389 to 3058 688 to 19   AAA   670/670
(100 %)
1 diff
(99.9 %id)
BM473048 duodenal adenocarcinoma, cell line, small intestine .c 2390 to 3058 1 to 669       669/674
(99 %)
3 diff
(99.6 %id)
TI_154128775   .c 2394 to 3061 812 to 144       669/815
(82 %)
0 diff
(100 %id)
CX868720 embryonic stem .c 2397 to 3060 690 to 27   AAA   664/664
(100 %)
1 diff
(99.9 %id)
BQ223868 melanotic melanoma, skin .c 2406 to 3042 1 to 647       647/1009
(64 %)
18 diff
(98.3 %id)
BU681186 lung .c 2427 to 3058 650 to 19   AAA   632/632
(100 %)
1 diff
(99.9 %id)
BM665471 eye, human retina .c 2427 to 3060 650 to 17   AAA   634/634
(100 %)
1 diff
(99.9 %id)
BU617884 Bone, Subchondral Bone .c 2427 to 3058 650 to 19   AAA   632/632
(100 %)
0 diff
(100 %id)
CA417657 Chondrosarcoma Cell line .c 2441 to 3058 636 to 19   AAA   618/618
(100 %)
5 diff
(99.2 %id)
BQ431293 melanotic melanoma, skin .c 2442 to 3061 1 to 620       620/650
(95 %)
1 diff
(99.9 %id)
BX433515 placenta .c 2445 to 3051 616 to 5       612/931
(65 %)
0 diff
(100 %id)
BM546079 ovary (pool of 3) .c 2447 to 3063 9 to 625       617/626
(98 %)
4 diff
(99.4 %id)
BQ233087 melanotic melanoma, skin .c 2447 to 3000 1 to 558       558/1036
(53 %)
11 diff
(99.0 %id)
CV815276 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 2449 to 3058 1 to 610   AAA   610/610
(100 %)
3 diff
(99.6 %id)
BU629535 cell lines, Chondrosarcoma .c 2454 to 3060 623 to 19   AAA   605/605
(100 %)
11 diff
(98.2 %id)
CA424311 cell lines, Chondrosarcoma .c 2458 to 3058 617 to 19   AAA   599/599
(100 %)
5 diff
(99.2 %id)
CA418545 Chondrosarcoma Grade II, Left Pelvis .c 2462 to 3060 617 to 19   AAA   599/608
(98 %)
2 diff
(99.7 %id)
BE727435 melanotic melanoma, skin .c 2467 to 3060 1 to 593   AAA   593/593
(100 %)
1 diff
(99.9 %id)
BU172653 melanotic melanoma, skin .c 2471 to 3058 1 to 588       588/588
(100 %)
0 diff
(100 %id)
FN061511 breast carcinoma .c 2479 to 2535 1 to 56       56/56
(100 %)
1 diff
(98.3 %id)
H98072 melanocyte .c 2505 to 3058 568 to 1       568/572
(99 %)
26 diff
(95.5 %id)
BU732752 eye, optic nerve .c 2524 to 3064 559 to 19   fully sequenced, AAA   541/541
(100 %)
1 diff
(99.9 %id)
BQ710884 Spleen .c 2526 to 3058 1 to 533   AAA   533/533
(100 %)
0 diff
(100 %id)
BU742328 eye, fetal eye .c 2540 to 3058 537 to 19   fully sequenced, AAA   519/519
(100 %)
7 diff
(98.7 %id)
BM998772 lung, Metastatic Chondrosarcoma .c 2543 to 3058 534 to 19   AAA   516/516
(100 %)
1 diff
(99.9 %id)
BU608852 Human Lung Epithelial cells, lung .c 2551 to 3058 526 to 19   AAA   508/508
(100 %)
5 diff
(99.1 %id)
BM669696 eye, fetal eyes .c 2552 to 3057 524 to 19   fully sequenced, AAA   506/506
(100 %)
0 diff
(100 %id)
AW250882 lung, small cell carcinoma .c 2553 to 3058 517 to 12   AAA   506/506
(100 %)
0 diff
(100 %id)
BF304341 muscle, rhabdomyosarcoma .c 2557 to 3064 1 to 509   AAA   509/509
(100 %)
4 diff
(99.3 %id)
BI195967 brain, neuroblastoma .c 2557 to 3058 1 to 502   AAA   502/502
(100 %)
1 diff
(99.9 %id)
BI195187 brain, neuroblastoma .c 2557 to 3048 1 to 491       491/770
(63 %)
3 diff
(99.7 %id)
BI194979 brain, neuroblastoma .c 2557 to 3058 1 to 501   AAA   501/501
(100 %)
2 diff
(99.7 %id)
CA424458 cell lines, Chondrosarcoma .c 2557 to 3058 521 to 19   AAA   503/503
(100 %)
2 diff
(99.7 %id)
AA552593 colon, tumor .c 2559 to 3056 498 to 1       498/498
(100 %)
2 diff
(99.6 %id)
BE379334 endometrium, adenocarcinoma cell line, uterus .c 2560 to 3061 1 to 505       505/731
(69 %)
13 diff
(98.3 %id)
BP391089 pancreatic islet .c 2562 to 3059 1 to 498     Submitted on the opposite strand 498/500
(99 %)
1 diff
(99.8 %id)
BM669387 eye, lens .c 2566 to 3058 511 to 19   AAA   493/493
(100 %)
3 diff
(99.4 %id)
AA709404 uterus .c 2567 to 3058 492 to 1       492/492
(100 %)
0 diff
(100 %id)
BP396914 pancreatic islet .c 2568 to 3063 1 to 496     Submitted on the opposite strand 496/501
(99 %)
1 diff
(99.9 %id)
BP386933 pancreatic islet .c 2569 to 3059 1 to 491     Submitted on the opposite strand 491/494
(99 %)
1 diff
(99.8 %id)
AW873147 adrenal gland, neuroblastoma .c 2577 to 3059 483 to 1       483/483
(100 %)
1 diff
(99.8 %id)
BU736257 eye, fetal eyes .c 2577 to 3054 498 to 21       478/498
(95 %)
0 diff
(100 %id)
BQ422025 epithelioid carcinoma, Pancreas .c 2582 to 3057 1 to 476       476/922
(51 %)
1 diff
(99.9 %id)
TI_154006808   .c 2585 to 3066 605 to 118   AAA   488/517
(94 %)
15 diff
(97.1 %id)
BM665723 eye, human retina .c 2587 to 3058 490 to 19   fully sequenced, AAA   472/472
(100 %)
1 diff
(99.8 %id)
DB507063 testis .c 2588 to 3058 1 to 472     Submitted on the opposite strand 472/472
(100 %)
16 diff
(96.7 %id)
AV702584 adrenal gland .c 2604 to 3058 1 to 455   AAA   455/455
(100 %)
1 diff
(99.8 %id)
AI937038 anaplastic oligodendroglioma, brain .c 2611 to 3061 457 to 7       451/457
(98 %)
0 diff
(100 %id)
DB541056 hippocampus .c 2616 to 3058 1 to 443   AAA Submitted on the opposite strand 443/443
(100 %)
2 diff
(99.6 %id)
AA151984 Pancreas .c 2617 to 3059 443 to 1       443/452
(98 %)
16 diff
(96.5 %id)
AI160941 heart .c 2617 to 3058 454 to 13   AAA   442/442
(100 %)
3 diff
(99.4 %id)
AL538792 brain, fetal brain .c 2618 to 3049 1 to 431   fully sequenced,   431/431
(100 %)
13 diff
(97.0 %id)
H17500 whole brain .c 2618 to 3061 474 to 11   AAA   464/464
(100 %)
20 diff
(95.7 %id)
R88426 brain .c 2619 to 3053 456 to 7       450/457
(98 %)
0 diff
(100 %id)
AA769102 germinal center B cell .c 2619 to 3058 490 to 50   AAA   441/441
(100 %)
5 diff
(98.9 %id)
AW190935 adenocarcinoma, Pancreas .c 2623 to 3043 421 to 1       421/421
(100 %)
3 diff
(99.3 %id)
AI991136 colon, colonic mucosa from 3 patients with Crohn'sdisease .c 2628 to 3061 437 to 3       435/437
(99 %)
0 diff
(100 %id)
AW085678 esophagus, squamous cell carcinoma .c 2628 to 3058 447 to 17   AAA   431/431
(100 %)
5 diff
(98.9 %id)
AW514735 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 2628 to 3058 441 to 11   AAA   431/431
(100 %)
1 diff
(99.8 %id)
AW675622 cervix .c 2628 to 3058 431 to 1       431/431
(100 %)
1 diff
(99.8 %id)
BG492112 amelanotic melanoma, cell line, skin .c 2630 to 3009 393 to 1   fully sequenced,   393/393
(100 %)
9 diff
(97.8 %id)
BE892708 melanotic melanoma, skin .c 2644 to 3057 1 to 415   AAA   415/415
(100 %)
9 diff
(97.9 %id)
BX423591 brain, fetal brain .c 2645 to 3029 388 to 1       388/932
(41 %)
7 diff
(99.3 %id)
D25677   .c 2647 to 2996 1 to 353     Submitted on the opposite strand 353/357
(98 %)
6 diff
(98.4 %id)
AA809403 germinal center B cell .c 2648 to 3017 370 to 1       370/370
(100 %)
3 diff
(99.2 %id)
AL538791 brain, fetal brain .c 2665 to 3029 365 to 1   fully sequenced,   365/365
(100 %)
10 diff
(97.3 %id)
W52172 senescent fibroblast .c 2665 to 3058 392 to 1       392/392
(100 %)
2 diff
(99.5 %id)
H18108 brain .c 2667 to 3056 394 to 1   fully sequenced,   394/394
(100 %)
8 diff
(98.0 %id)
AI049928   .c 2667 to 3061 396 to 2       395/396
(99 %)
0 diff
(100 %id)
BM478706 melanotic melanoma, skin .c 2670 to 3058 1 to 389   AAA   389/389
(100 %)
0 diff
(100 %id)
AA552424 colon, tumor .c 2671 to 3058 388 to 1       388/388
(100 %)
1 diff
(99.8 %id)
AA324880 brain, cerebellum .c 2674 to 3059 392 to 2     Submitted on the opposite strand 391/395
(98 %)
0 diff
(100 %id)
W92991 heart .c 2686 to 3058 387 to 13   AAA   375/375
(100 %)
7 diff
(98.2 %id)
AI364515 anaplastic oligodendroglioma, brain .c 2695 to 3057 363 to 1       363/363
(100 %)
0 diff
(100 %id)
AI648516 ovary, tumor, 5 pooled (see description) .c 2697 to 3059 363 to 1       363/363
(100 %)
0 diff
(100 %id)
AA485734 ovarian tumor, ovary .c 2698 to 3062 365 to 1   fully sequenced,   365/365
(100 %)
4 diff
(99.0 %id)
H41112 brain .c 2707 to 3042 359 to 17       343/400
(85 %)
0 diff
(100 %id)
AI208906   .c 2711 to 3062 371 to 20   AAA   352/352
(100 %)
1 diff
(99.8 %id)
AA639864 colon, colon tumor RER+ .c 2714 to 3059 349 to 4       346/349
(99 %)
0 diff
(100 %id)
AA854011   .c 2715 to 3059 351 to 7       345/351
(98 %)
0 diff
(100 %id)
AA678516   .c 2716 to 3061 346 to 2       345/346
(99 %)
0 diff
(100 %id)
AI223023   .c 2717 to 3062 365 to 20   AAA   346/346
(100 %)
3 diff
(99.2 %id)
AI097446 brain, glioblastoma (pooled) .c 2723 to 3057 338 to 4       335/338
(99 %)
0 diff
(100 %id)
AA765348 germinal center B cell .c 2725 to 3045 319 to 1       319/319
(100 %)
4 diff
(98.8 %id)
AA250968.
matches multiple genes
germinal center B cell .c 2726 to 3055 364 to 35   AAA also hits gene pysabo 330/330
(100 %)
2 diff
(99.4 %id)
T54339 placenta .c 2729 to 3058 349 to 21   AAA   329/331
(99 %)
4 diff
(98.8 %id)
R89522 brain .c 2729 to 3032 305 to 1       305/306
(99 %)
13 diff
(95.8 %id)
AI016385   .c 2729 to 3059 333 to 3       331/333
(99 %)
0 diff
(100 %id)
BE151898 head_neck .c 2731 to 3058 1 to 329       329/342
(96 %)
17 diff
(95.1 %id)
BQ356522 head_neck .c 2732 to 3058 39 to 366       328/379
(86 %)
29 diff
(92.4 %id)
D53226   .c 2732 to 3053 1 to 320       320/320
(100 %)
2 diff
(99.4 %id)
AA974279 pooled germ cell tumors .c 2737 to 3058 322 to 1       322/322
(100 %)
0 diff
(100 %id)
AI563971 anaplastic oligodendroglioma, brain .c 2742 to 3058 334 to 18   AAA   317/317
(100 %)
1 diff
(99.7 %id)
BU732305 eye, RPE and Choroid .c 2764 to 3058 313 to 19   AAA   295/295
(100 %)
0 diff
(100 %id)
CA434781 lung, Metastatic Chondrosarcoma .c 2766 to 3066 319 to 19   AAA   301/301
(100 %)
0 diff
(100 %id)
H46149 brain .c 2792 to 3042 262 to 14       249/262
(95 %)
0 diff
(100 %id)
BE925437 amnion_normal .c 2807 to 3025 108 to 327       220/327
(67 %)
6 diff
(98.2 %id)
AL135224 melanoma (MeWo cell line) .c 2810 to 3058 1 to 249   AAA   249/249
(100 %)
1 diff
(99.6 %id)
AL135233 melanoma (MeWo cell line) .c 2810 to 3058 1 to 249   AAA   249/249
(100 %)
4 diff
(98.4 %id)
AA583601 larynx .c 2817 to 3056 267 to 29   AAA   239/239
(100 %)
1 diff
(99.6 %id)
AW198165 adenocarcinoma, Pancreas .c 2830 to 3059 231 to 2       230/231
(99 %)
0 diff
(100 %id)
BM470309 eye, retinoblastoma .c 2839 to 3060 43 to 264   AAA   222/264
(84 %)
6 diff
(97.8 %id)
H38440 brain .c 2847 to 3044 198 to 1       198/198
(100 %)
2 diff
(99.0 %id)
AW248808 lung, small cell carcinoma .c 2851 to 3057 217 to 11   AAA   207/207
(100 %)
2 diff
(99.1 %id)
AK302222 testis .d 1 to 1792 1 to 1792 L184P tiling clone,   1792/1792
(100 %)
2 diff
(99.9 %id)
DC398598 testis .d 1 to 571 1 to 571       571/571
(100 %)
2 diff
(99.7 %id)
BX409593 brain, fetal brain .d 183 to 978 1 to 796   tiling clone,   796/811
(98 %)
7 diff
(99.2 %id)
BG027274 Bone, osteosarcoma, cell line .d 363 to 1016 1 to 658       658/744
(88 %)
11 diff
(98.6 %id)
CX872993 embryonic stem .e 1 to 745 1 to 745   tiling clone,   745/745
(100 %)
0 diff
(100 %id)
CB155139 brain .e 8 to 278 1 to 271       271/271
(100 %)
2 diff
(99.3 %id)
CN285477 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .e 84 to 635 1 to 552       552/552
(100 %)
1 diff
(99.9 %id)
BX461740 brain, fetal brain .e 185 to 1176 1 to 981       981/981
(100 %)
13 diff
(98.7 %id)
DB023808 testis .e 266 to 815 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
BG385536 adenocarcinoma cell line, colon .e 407 to 1144 1 to 732       732/903
(81 %)
14 diff
(98.5 %id)
AL120211 amygdala .e 414 to 903 1 to 490       490/491
(99 %)
3 diff
(99.4 %id)
BM463035 melanotic melanoma, skin .e 477 to 1308 1 to 838   tiling clone,   838/1126
(74 %)
15 diff
(98.7 %id)
BF355309 head_neck .e 1159 to 1685 551 to 24   tiling clone,   528/551
(95 %)
1 diff
(99.9 %id)
BF946990 nervous_normal .e 1347 to 1822 488 to 9   tiling clone,   480/506
(94 %)
0 diff
(100 %id)
AJ705154 bone marrow .e 1610 to 1895 6 to 291   tiling clone,   286/291
(98 %)
6 diff
(98.0 %id)
TI_44165954   .f 1 to 753 142 to 908 E44R I45D E46* tiling clone,   769/922
(83 %)
25 diff
(97.3 %id)
DB035383 testis .g 1 to 551 2 to 552   tiling clone, capped   551/551
(100 %)
0 diff
(100 %id)
DB048309 testis .g 9 to 567 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
DB024041 testis .g 29 to 573 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DB036532 testis .g 31 to 602 2 to 573 I83T D159Y tiling clone, capped   572/572
(100 %)
3 diff
(99.5 %id)
DB048122 testis .g 31 to 582 2 to 553   tiling clone, capped   552/552
(100 %)
0 diff
(100 %id)
CR615880 Placenta Cot 25-normalized .h 1 to 1474 1 to 1474 exact tiling clone,   1474/1474
(100 %)
0 diff
(100 %id)
BY994546   .i 1 to 684 10 to 692 exact tiling clone,   683/692
(98 %)
8 diff
(98.9 %id)
CF125872 Chondrosarcoma Lung Metastasis cell lines, lung .j 1 to 292 1 to 292       292/292
(100 %)
1 diff
(99.7 %id)
CF126041 Chondrosarcoma Lung Metastasis cell lines, lung .j 1 to 555 1 to 555       555/555
(100 %)
0 diff
(100 %id)
TI_154187527   .j 1 to 798 131 to 922 N59X G104X A110R G111W P126X ... tiling clone,   792/951
(83 %)
15 diff
(98.5 %id)
BM146469 leukopheresis .k 1 to 486 3 to 487   tiling clone,   487/487
(100 %)
4 diff
(99.2 %id)
BP237141 coronary artery .k 7 to 597 1 to 587   tiling clone,   587/588
(99 %)
16 diff
(97.3 %id)
BP219629 caudate nucleus .k 26 to 607 1 to 582 exact tiling clone,   582/582
(100 %)
3 diff
(99.5 %id)
BE843746 testis_normal .l-u -9 to 288 30 to 328   tiling clone,   299/328
(91 %)
9 diff
(97.3 %id)
AI379205 B-cell, chronic lymphotic leukemia .l-u 157 to 399 442 to 200   tiling clone, AAA   243/431
(56 %)
0 diff
(100 %id)
AW803436 uterus .l-u 263 to 728 9 to 474   tiling clone,   466/474
(98 %)
6 diff
(98.8 %id)
CN365611 embryonic stem cells, cell lines H1, H7, andH9 .m 1 to 667 1 to 666 exact tiling clone,   666/666
(100 %)
2 diff
(99.7 %id)
CV330583 colon .m 99 to 360 1 to 262       262/262
(100 %)
11 diff
(95.9 %id)
BM549957 leukocyte .n 1 to 859 17 to 885 exact tiling clone,   869/1058
(82 %)
27 diff
(97.5 %id)
BE892927 melanotic melanoma, skin .n 355 to 893 1 to 559   tiling clone,   559/729
(76 %)
35 diff
(95.2 %id)
AI350419 pooled germ cell tumors .o 1 to 319 344 to 26 exact tiling clone,   319/344
(92 %)
0 diff
(100 %id)
CN365605 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .o 100 to 309 1 to 210   AAA   210/210
(100 %)
5 diff
(97.7 %id)
AI283630 Kidney .o 107 to 308 207 to 6       202/207
(97 %)
0 diff
(100 %id)
BE206590 Kidney, renal cell adenocarcinoma .o 112 to 308 200 to 4       197/200
(98 %)
0 diff
(100 %id)
BQ424457 melanotic melanoma, skin .o 118 to 307 1 to 190   AAA   190/190
(100 %)
0 diff
(100 %id)
AA100930   .o 149 to 306 187 to 31   AAA   157/157
(100 %)
5 diff
(96.9 %id)
BM974368 lung .o 169 to 307 157 to 19   AAA   139/148
(93 %)
0 diff
(100 %id)
BU754595 placenta .o 182 to 307 144 to 19   AAA   126/134
(94 %)
0 diff
(100 %id)
BU178717 eye, retinoblastoma .o 193 to 311 1 to 119   AAA   119/119
(100 %)
0 diff
(100 %id)
GD156107   .o 231 to 307 1 to 77   AAA   77/77
(100 %)
2 diff
(97.5 %id)
CR599804 thymus .p 1 to 1477 1 to 1477 exact tiling clone,   1477/1477
(100 %)
0 diff
(100 %id)
TI_45214565   .q-u 1 to 853 82 to 926       845/946
(89 %)
28 diff
(97.1 %id)
BI603838 brain, hypothalamus .q-u 6 to 853 1 to 841   tiling clone,   841/861
(97 %)
26 diff
(97.0 %id)
CN365594 embryonic stem cells, DMSO-treated H9 cellline .q-u 62 to 804 1 to 743   tiling clone,   743/743
(100 %)
1 diff
(99.9 %id)
BE769512 prostate_tumor .q-u 323 to 841 12 to 530       519/530
(97 %)
6 diff
(98.9 %id)
BE769582 prostate_tumor .q-u 323 to 659 60 to 396       337/396
(85 %)
6 diff
(98.5 %id)
BM796873 Ascites, stomach .q-u 495 to 1016 1 to 522       522/522
(100 %)
1 diff
(99.9 %id)
TI_57190568   .q-u 506 to 1254 54 to 822       769/779
(98 %)
34 diff
(95.7 %id)
BI859042 breast, mammary adenocarcinoma, cell line .q-u 507 to 1254 1 to 768       768/778
(98 %)
34 diff
(95.7 %id)
CN365610 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .q-u 538 to 1197 1 to 661       661/661
(100 %)
3 diff
(99.6 %id)
BG756845 B-cells, primary B-cells from tonsils (cell line) .q-u 538 to 1168 1 to 628       628/628
(100 %)
4 diff
(99.4 %id)
BU956945 adenocarcinoma, cell line, breast .q-u 566 to 1198 1 to 633       633/894
(70 %)
9 diff
(99.0 %id)
BG251130 adenocarcinoma, cell line, Liver .q-u 588 to 1285 1 to 694 R24H Q70K S71A C72V S73L ... tiling clone,   694/694
(100 %)
5 diff
(99.3 %id)
BM913478 amelanotic melanoma, cell line, skin .q-u 646 to 1275 1 to 630 T68X Q70P V75P W76G G78R ... tiling clone,   630/1047
(60 %)
8 diff
(99.3 %id)
BM707863 eye, RPE and Choroid .q-u 755 to 1240 1 to 486       486/486
(100 %)
1 diff
(99.8 %id)
BQ924471 large cell carcinoma, lung .r 1 to 946 1 to 946 exact tiling clone,   946/955
(99 %)
13 diff
(98.7 %id)
AL079784 testis .s 1 to 573 7 to 573   tiling clone,   573/574
(99 %)
9 diff
(98.5 %id)
BU182483 melanotic melanoma, skin .s 19 to 823 1 to 807 K71Q E74K S77P L79V K80E ... tiling clone,   807/858
(94 %)
14 diff
(98.4 %id)
DA793362 brain .s 37 to 581 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
BM905596 embryonal carcinoma, cell line, testis .t 1 to 609 5 to 610 Q17H K31R N33C K43S E44Q ... tiling clone,   557/999
(55 %)
30 diff
(97.0 %id)
DA692250   .u -9 to 528 2 to 540 exact tiling clone, capped   539/539
(100 %)
2 diff
(99.7 %id)
AA381306   .va-u 1 to 329 1 to 329 W57L tiling clone,   329/329
(100 %)
2 diff
(99.4 %id)
AK303524 thymus Gene RANGAP1, variant not shown         Suspected internal deletion, this clone was ignored    
BQ942124 sciatic nerve Gene RANGAP1, variant not shown              
BU527989 epidermoid carcinoma, cell line, lung Gene RANGAP1, variant not shown              
BU528076 epidermoid carcinoma, cell line, lung Gene RANGAP1, variant not shown              
BU957629 adenocarcinoma, cell line, breast Gene RANGAP1, variant not shown              
TI_159677544   Gene RANGAP1, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l-u, .m, .n, .o, .p, .q-u, .r, .s, .t, .u, .va-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI